Home pregnancy progression testing system and method

1. A home pregnancy testing viability system, consisting of:

a first test having a first test strip in communication with a first viewing window, a first marker presented on the first test strip to indicate positive or negative, a first antibody in fluid communication with the first test strip, the first antibody having a first sensitivity of approximately 20 mIU of human chorionic gonadotropin (hCG), and a first label stating day 1 marked on a top surface of the first test, wherein day 1 is the first day in which the user receives a positive result when taking the test having the approximately 20 mIU hCG sensitivity;

a second test having a second test strip in communication with a second viewing window, a second marker presented on the second test strip to indicate positive or negative, a second antibody in fluid communication with the second test strip, the second antibody having a second sensitivity of approximately 40 mIU of hCG, and a second label stating day 3 marked on a top surface of the second test;

a third test having a third test strip in communication with a third viewing window, a third marker presented on the third test strip to indicate positive or negative, a third antibody in fluid communication with the third test strip, the third antibody having a third sensitivity of approximately 80 mIU of hCG, and a third label stating day 5 on a top surface of the third test;

a fourth test having a fourth test strip in communication with a fourth viewing window, a fourth marker presented on the fourth test strip to indicate positive or negative, a fourth antibody in fluid communication with the fourth test strip, the fourth antibody having a fourth sensitivity of approximately 160 mIU of hCG, and a fourth label stating day 7 on a top surface of the third test;

a fifth test having a fifth test strip in communication with a fifth viewing window, a fifth marker presented on the fifth test strip to indicate positive or negative, a fifth antibody in fluid communication with the fifth test strip, the fifth antibody having a fifth sensitivity of approximately 320 mIU of hCG, and a fifth label stating day 9 on a top surface of the fifth test; and

a sixth test having a sixth test strip in communication with a sixth viewing window, a sixth marker presented on the sixth test strip to indicate positive or negative, a sixth antibody in fluid communication with the sixth test strip, the sixth reactant antibody having a sixth sensitivity of approximately 640 mIU of hCG, and a sixth label stating day 11 on a top surface of the sixth test;

wherein a plurality of positive results associated with the first, second, third, fourth, fifth, and sixth tests indicate a progressing pregnancy; and

wherein the first, second, third, fourth, fifth, and sixth test are packaged together.

2. A home pregnancy test viability system, consisting of:

a group of six tests, each test of the group of six tests having a test strip configured to receive a sample;

a device, being independent of the group of six tests, the device having a test strip receiver configured to receive each test of the group of six tests independently on a predetermined schedule, the predetermined schedule being a first test on day 1, a second test on day 3, a third test on day 5, a fourth test on day 7, a fifth test on day 9, and a sixth test on day 11;

a processor in communication with the test receiver to analyze the test strip to determine if the test strip tests positive for a predetermined level of human chorionic gonadotropin (hCG) as determined based on the predetermined schedule, the predetermined level of human chorionic gonadotropin (hCG) for the predetermined schedule being 20 mIU on day 1, 40 mIU on day 3, 80 mIU on day 5, 160 mIU on day 7, 320 mIU on day 9, and 640 mIU on day 11, wherein day 1 is the first day in which the user receives a positive result at 20 mIU hCG sensitivity; and

a screen associated with the device, the screen displaying the predetermined schedule wherein results are provided on the screen indicating a potential progression in pregnancy based on the sample of each test of the group of six tests, and wherein the screen showing a six positive determinations of the group of six tests over the predetermined schedule is indicative of the potential progression in pregnancy.